BioAmber (BIOA) Tops Q3 EPS by 18c

BioAmber (NYSE: BIOA) reported Q3 revenue for the quarter came in at $631 thousand versus the consensus estimate of $3.78 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk
• DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)